中 / EN
October 2026

Shanghai Ninth People's Hospital Leads Trial of Auditory Brainstem Implant That Receives Approval in China

According to Sanbo Brain Hospital, China's National Medical Products Administration has approved the registration of an auditory brainstem implant. Professor Wu Hao of Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, led the device trial, with a team from Sanbo Brain Hospital, Capital Medical University, participating as site investigators. Intended for hearing reconstruction, the device is indicated for prelingually deaf patients aged 2-6 years, excluding those aged 6, with non-tumor-related, non-syndromic deafness and specified severe inner ear malformations or an absent cochlear nerve that prevent cochlear implantation. It stimulates the cochlear nucleus at the brainstem surface, bypassing the cochlea and auditory nerve, and works with a cochlear implant speech processor.

Neuracle Lists K1014-15 Implantable EEG Electrode Kit in UDI Database

Neuracle Medical Technology (Shanghai) Co., Ltd. listed its K1014-15 Implantable EEG Electrode Kit in the National Medical Products Administration's medical device unique identification database. The entry describes a kit containing a cortical electrode (1014-15) and supporting components, forming part of an implantable BCI hand motor function compensation system. The complete system also includes a BCI implant, an EEG transceiver, pneumatic glove equipment, and related software. The record identifies the kit and its relationship to the system; UDI listing itself is neither a new marketing authorization nor evidence of safety or improved hand function in patients.

Neuracle Lists Model 1014-15 Cortical Electrode in NMPA UDI Database

Neuracle Medical Technology (Shanghai) Co., Ltd. listed its Model 1014-15 cortical electrode in the National Medical Products Administration's medical device unique identification database. The entry identifies the electrode as a component of an implantable EEG electrode kit, which forms part of an implantable BCI hand motor function compensation system. The system also includes a BCI implant, an EEG transceiver, pneumatic glove equipment, and related software. The record specifies the electrode's model, identifier, and relationship to the system; UDI listing itself is neither a new marketing authorization nor clinical evidence of improved hand function.

Neuracle Lists K1014-35 Implantable EEG Electrode Kit in UDI Database

Neuracle Medical Technology (Shanghai) Co., Ltd. listed its K1014-35 Implantable EEG Electrode Kit in the National Medical Products Administration's medical device unique identification database. The entry describes a kit containing a cortical electrode (1014-35) and supporting components, forming part of an implantable BCI hand motor function compensation system. The complete system also includes a BCI implant, an EEG transceiver, pneumatic glove equipment, and related software. The record identifies the kit and its relationship to the system; UDI listing itself is neither a new marketing authorization nor evidence of safety or functional improvement in patients.

Neuracle Lists Model 1014-25 Cortical Electrode in NMPA UDI Database

Neuracle Medical Technology (Shanghai) Co., Ltd. listed its Model 1014-25 cortical electrode in the National Medical Products Administration's medical device unique identification database. The entry identifies the electrode as part of an implantable EEG electrode kit, which is a component of an implantable BCI hand motor function compensation system. The full system also includes a BCI implant, an EEG transceiver, pneumatic glove equipment, and related software. The record identifies the electrode and its relationship to the kit and system; UDI listing itself is neither a new marketing authorization nor clinical evidence of improved hand function.

Neuracle Lists Implanted EEG Electrode Kit in NMPA UDI Database

Neuracle Medical Technology (Shanghai) Co., Ltd. listed an Implanted EEG Electrode Kit, Model K1014-25, in the National Medical Products Administration's medical device unique identification database. The entry describes a kit containing a cortical electrode (1014-25) and supporting components, forming part of an implanted BCI hand motor function compensation system. The system also includes a BCI implant, an EEG transceiver, pneumatic glove equipment, and related software. The record identifies the kit and its relationship to the system; UDI listing itself is neither a new marketing authorization nor evidence of functional improvement in patients.

Neuracle Lists Cortical Electrode in NMPA UDI Database

Neuracle Medical Technology (Shanghai) Co., Ltd. listed its Model 1014-35 cortical electrode in the National Medical Products Administration's medical device unique identification database. The entry identifies the electrode as a component of an implanted EEG electrode kit, which in turn forms part of an implanted BCI hand motor function compensation system. The system also includes a BCI implant, an EEG transceiver, pneumatic glove equipment, and related software. The entry clarifies these component relationships; UDI listing itself is neither a new marketing authorization nor evidence of clinical effectiveness.

Neuracle UDI Listings Cover Two BCI System Models and Two Electrode Kit Models

China’s NMPA UDI database lists Neuracle’s NEO-M and NEO-M Pro hand motor function compensation system models under registration certificate 国械注准20263120537, and K1014-25 and K1014-35 implantable EEG electrode kits under 国械注准20263120536. The descriptions identify the system’s implantable components, EEG transceiver, pneumatic glove and software.
September 2026

FDA Clears Ceribell EEG Analysis Software Under 510(k)

The US Food and Drug Administration has cleared EEG Analysis Software from Ceribell, a US medical device company, through the 510(k) pathway after finding it substantially equivalent to a device already on the market. The software performs quantitative analysis of EEG signals and is regulated as a Class II device under the Neurology review panel. A 510(k) clearance only requires showing equivalence to an existing product, a lower bar than the premarket approval required for high-risk devices. The FDA record does not describe the software's indications or specific analysis functions.

Neuracle Registers Cortical Electrode in China's NMPA Device Identifier Database

Neuracle Medical Technology (Shanghai) Co., Ltd. has registered a cortical electrode, model 1014-35, in the medical device unique identification (UDI) database of China's National Medical Products Administration (NMPA), under registration certificate Guoxiezhuzhun 20263120536. Neuracle's product line spans EEG acquisition equipment and implantable electrodes. The electrode belongs to an implantable EEG electrode kit (cortical electrode, blank electrode, electrode dilator, tunneler, torque wrench, lead fixation clip, fixation screws and electrode protective sleeve) that holds its own registration certificate and is also a component of an implantable BCI hand motor function compensation system. That system comprises a BCI implant, the electrode kit, an EEG signal transceiver, a pneumatic glove, a single-use surgical toolkit, and three software packages for EEG decoding, medical testing and clinical management.

FDA Clears Pascall Systems' EEG Software Under 510(k)

Pascall Systems, Inc. received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Pascall Sensor Unit (PSU1) on August 19, 2026, with the agency finding the device substantially equivalent. The device is a Class II medical device under regulation number 882.1400, classification name Non-Normalizing Quantitative Electroencephalograph Software.
August 2026
July 2026

NeuroXess 'Sanquan' BCI Enters CMDE Innovative Medical Device Review Program

NeuroXess announced that its self-developed implantable brain-computer interface system for hand motor function compensation — the 'fully implanted, fully wireless, fully functional' ('Sanquan') system — has passed public notice and formally entered the innovative medical device special review program of the National Medical Products Administration's Center for Medical Device Evaluation (CMDE), commonly known as the green channel. The company describes it as the first subdural implantable flexible BCI product in China to enter the program. The system began a GCP registration clinical trial at Huashan Hospital, Fudan University on July 7, 2026, run as a multicentre study across 15 Class III hospitals nationwide, with trial data intended to support a Class III medical device registration application with the NMPA. The system remains in the review and clinical-trial stage and has not yet been approved for market; the registration timeline reflects company statements and remains subject to regulatory notice.
June 2026

FDA Approves Label Changes for Saluda Medical's Spinal Cord Stimulators

The FDA approved a premarket approval (PMA) supplement, S039, from Saluda Medical Pty, Ltd. on June 29, 2026, covering the CAP24 Paddle Lead, Passing Elevator, Evoke CLS (REF 3042), Clarity Programming Application (CPA) and RECAP Viewer. The supplement is a labeling change touching indications, instructions for use, shelf life and trade name rather than an original approval of a new device; the products carry the generic name 'stimulator, spinal-cord, totally implanted for pain relief.' Saluda Medical is an Australian company whose Evoke system is one of the few closed-loop spinal cord stimulators on the market.

Neuracle Registers UDI for Implantable EEG Electrode Kit

Neuracle Medical Technology (Shanghai) Co., Ltd. registered an Implantable EEG Electrode Kit in the NMPA Medical Device Unique Identification database. The model is K1014-15, and the registration certificate number is 国械注准20263120536. The listed kit includes a cortical electrode, a blank electrode, and surgical and fixation components. It is both a product with its own registration certificate and a component of an implantable brain-computer interface hand motor function compensation system. The system also includes an implant, an EEG transceiver, a pneumatic glove device, and software. This entry identifies the product and its composition; it does not establish the complete system's registration status or clinical performance.

Neuracle Registers UDI for NEO-M Hand Motor Function Compensation System

Neuracle registered the NEO-M Implantable Brain-Computer Interface Hand Motor Function Compensation System in the NMPA Medical Device Unique Identification database. Its registration certificate number is 国械注准20263120537. According to the company's description, the system includes a BCI implant, an implantable EEG electrode kit, a disposable surgical tool kit, an EEG signal transceiver, a pneumatic glove device, and EEG decoding, medical testing, and clinical management software. All three software products have release version 1.0. The entry identifies the product and its components; UDI registration itself does not validate clinical efficacy or safety.

Neuracle Registers UDI for K1014-35 Implantable EEG Electrode Kit

Neuracle Medical Technology (Shanghai) Co., Ltd. registered the K1014-35 Implantable EEG Electrode Kit in the NMPA Medical Device Unique Identification database. Its registration certificate number is 国械注准20263120536. The company's description lists a cortical electrode, a blank electrode, and associated tools and fixation components. It describes the kit as both a product with its own registration certificate and a component of an implantable brain-computer interface hand motor function compensation system. The notes also list an EEG transceiver, a pneumatic glove device, and software within that system. The kit's UDI entry alone does not confirm the complete system's registration status or clinical performance.

Neuracle Registers UDI for K1014-25 Implantable EEG Electrode Kit

Neuracle Medical Technology (Shanghai) Co., Ltd. registered the K1014-25 Implantable EEG Electrode Kit in the NMPA Medical Device Unique Identification database. Its registration certificate number is 国械注准20263120536. According to the company's registered description, the kit includes a cortical electrode, a blank electrode, and associated tools and fixation components. It is both a product with its own registration certificate and a component of an implantable brain-computer interface hand motor function compensation system. The entry also lists the system's EEG transceiver, pneumatic glove device, and software. It identifies the kit and its relationship to the system; UDI registration itself does not validate clinical efficacy or safety.

Neuracle Registers UDI for NEO-M Pro Hand Motor Function Compensation System

Neuracle Medical Technology (Shanghai) Co., Ltd. registered the Implantable Brain-Computer Interface Hand Motor Function Compensation System in the NMPA Medical Device Unique Identification database. Its model is NEO-M Pro, and its registration certificate number is 国械注准20263120537. The description lists a BCI implant, an implantable EEG electrode kit, a disposable surgical tool kit, an EEG signal transceiver, a pneumatic glove device, and three software products, each with release version 1.0. The entry provides product identification and composition information; UDI registration itself should not be interpreted as validation of clinical efficacy or safety.
January 2026

BrainCo Registers FocusXin ADHD Hardware and Software as Class II Devices

BrainCo's FocusXin Medical Edition combines a single-channel prefrontal EEG device registered as 浙械注准20232071898 with ADHD rehabilitation software registered as 浙械注准20252211934. The Class II system is intended for supplementary rehabilitation training in children aged 6 to 12 with ADHD. Its defined medical use should not be generalized into approval for an unspecified consumer BCI product.
September 2025
February 2023
November 2021

FDA Grants Breakthrough Status to Blackrock Neurotech's MoveAgain BCI

The FDA granted Breakthrough Device designation to Blackrock Neurotech's MoveAgain BCI System on November 16, 2021. The investigational system combines an implanted array, neural decoding and wireless output with the goal of allowing people with severe paralysis to control digital and assistive devices. The designation can expedite development and review but is not market approval.
October 2021
May 2021
© 2026 BCIwiki.com Digest Topics Tips Subscribe Revisions About